BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 25667420)

  • 1. Effect of prior cancer on outcomes in advanced lung cancer: implications for clinical trial eligibility and accrual.
    Laccetti AL; Pruitt SL; Xuan L; Halm EA; Gerber DE
    J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25667420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revisiting a longstanding clinical trial exclusion criterion: impact of prior cancer in early-stage lung cancer.
    Pruitt SL; Laccetti AL; Xuan L; Halm EA; Gerber DE
    Br J Cancer; 2017 Mar; 116(6):717-725. PubMed ID: 28196065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of statins on survival in patients with stage IV lung cancer.
    Lin JJ; Ezer N; Sigel K; Mhango G; Wisnivesky JP
    Lung Cancer; 2016 Sep; 99():137-42. PubMed ID: 27565929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prior cancer does not adversely affect survival in locally advanced lung cancer: A national SEER-medicare analysis.
    Laccetti AL; Pruitt SL; Xuan L; Halm EA; Gerber DE
    Lung Cancer; 2016 Aug; 98():106-113. PubMed ID: 27393515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-world effectiveness of systemic agents approved for advanced non-small cell lung cancer: a SEER-Medicare analysis.
    Owonikoko TK; Ragin C; Chen Z; Kim S; Behera M; Brandes JC; Saba NF; Pentz R; Ramalingam SS; Khuri FR
    Oncologist; 2013; 18(5):600-10. PubMed ID: 23635558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of prior cancer on eligibility for lung cancer clinical trials.
    Gerber DE; Laccetti AL; Xuan L; Halm EA; Pruitt SL
    J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25253615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonologist involvement, stage-specific treatment, and survival in adults with non-small cell lung cancer and chronic obstructive pulmonary disease.
    Deepak JA; Ng X; Feliciano J; Mao L; Davidoff AJ
    Ann Am Thorac Soc; 2015 May; 12(5):742-51. PubMed ID: 25760983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of prior cancer on trial eligibility and treatment outcomes in nasopharyngeal carcinoma: Implications for clinical trial accrual.
    Wang YQ; Lv JW; Tang LL; Du XJ; Chen L; Li WF; Liu X; Guo Y; Lin AH; Mao YP; Sun Y; Chen YP; Ma J
    Oral Oncol; 2019 Mar; 90():23-29. PubMed ID: 30846172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin vs. carboplatin-based chemoradiotherapy in patients >65 years of age with stage III non-small cell lung cancer.
    Ezer N; Smith CB; Galsky MD; Mhango G; Gu F; Gomez J; Strauss GM; Wisnivesky J
    Radiother Oncol; 2014 Aug; 112(2):272-8. PubMed ID: 25150635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermal ablation matches sublobar resection outcomes in older patients with early-stage non-small cell lung cancer.
    Kwan SW; Mortell KE; Talenfeld AD; Brunner MC
    J Vasc Interv Radiol; 2014 Jan; 25(1):1-9.e1. PubMed ID: 24365502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generalizability of trial results to elderly Medicare patients with advanced solid tumors (Alliance 70802).
    Lamont EB; Schilsky RL; He Y; Muss H; Cohen HJ; Hurria A; Meilleur A; Kindler HL; Venook A; Lilenbaum R; Niell H; Goldberg RM; Joffe S;
    J Natl Cancer Inst; 2015 Jan; 107(1):336. PubMed ID: 25432408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival of older patients with cancer in the Veterans Health Administration versus fee-for-service Medicare.
    Landrum MB; Keating NL; Lamont EB; Bozeman SR; Krasnow SH; Shulman L; Brown JR; Earle CC; Rabin M; McNeil BJ
    J Clin Oncol; 2012 Apr; 30(10):1072-9. PubMed ID: 22393093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.
    Iezzoni LI; Ngo LH; Li D; Roetzheim RG; Drews RE; McCarthy EP
    Arch Phys Med Rehabil; 2008 Apr; 89(4):595-601. PubMed ID: 18373987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends, predictors, and impact of systemic chemotherapy in small cell lung cancer patients between 1985 and 2005.
    Behera M; Ragin C; Kim S; Pillai RN; Chen Z; Steuer CE; Saba NF; Belani CP; Khuri FR; Ramalingam SS; Owonikoko TK
    Cancer; 2016 Jan; 122(1):50-60. PubMed ID: 26441041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic body radiotherapy versus lobectomy for operable clinical stage IA lung adenocarcinoma: comparison of survival outcomes in two clinical trials with propensity score analysis (JCOG1313-A).
    Eba J; Nakamura K; Mizusawa J; Suzuki K; Nagata Y; Koike T; Hiraoka M; Watanabe S; Ishikura S; Asamura H; Fukuda H;
    Jpn J Clin Oncol; 2016 Aug; 46(8):748-53. PubMed ID: 27174959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules.
    Altorki NK; Yip R; Hanaoka T; Bauer T; Aye R; Kohman L; Sheppard B; Thurer R; Andaz S; Smith M; Mayfield W; Grannis F; Korst R; Pass H; Straznicka M; Flores R; Henschke CI;
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):754-62; Discussion 762-4. PubMed ID: 24280722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Prior Malignancy on Survival Outcomes of Stage IV Pancreatic Adenocarcinoma: SEER-Based Cohort.
    Al-Husseini MJ; Saad AM; Turk T; Tabash MA; Abdel-Rahman O
    J Gastrointest Cancer; 2019 Dec; 50(4):794-800. PubMed ID: 30105523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of survival and hospitalization rates between Medicare patients with advanced NSCLC treated with bevacizumab-carboplatin-paclitaxel and carboplatin-paclitaxel: a retrospective cohort study.
    Langer C; Ravelo A; Hazard SJ; Guerin A; Ionescu-Ittu R; Latremouille-Viau D; Wu EQ; Ramalingam S
    Lung Cancer; 2014 Dec; 86(3):350-7. PubMed ID: 25439437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of prior malignancies on outcome of colorectal cancer; revisiting clinical trial eligibility criteria.
    Al-Husseini MJ; Saad AM; Mohamed HH; Alkhayat MA; Sonbol MB; Abdel-Rahman O
    BMC Cancer; 2019 Aug; 19(1):863. PubMed ID: 31470823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of estrogen monotherapy on survival in women with stage III-IV non-small cell lung cancer.
    Heilbroner SP; Xanthopoulos EP; Buono D; Huang Y; Carrier D; Shah A; Kim J; Corradetti M; Wright JD; Neugut AI; Hershman DL; Cheng SK
    Lung Cancer; 2019 Mar; 129():8-15. PubMed ID: 30797496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.